APA (7th ed.) Citation

Oeckl, P., Halbgebauer, S., Straub, S., Arnim, C. v., Diehl-Schmid, J., Frölich, L., . . . Otto, M. (2020). Targeted mass spectrometry suggests beta-synuclein as synaptic blood marker in Alzheimer’s disease. Journal of proteome research, 19(3), . https://doi.org/10.1021/acs.jproteome.9b00824

Chicago Style (17th ed.) Citation

Oeckl, Patrick, et al. "Targeted Mass Spectrometry Suggests Beta-synuclein as Synaptic Blood Marker in Alzheimer’s Disease." Journal of Proteome Research 19, no. 3 (2020). https://doi.org/10.1021/acs.jproteome.9b00824.

MLA (9th ed.) Citation

Oeckl, Patrick, et al. "Targeted Mass Spectrometry Suggests Beta-synuclein as Synaptic Blood Marker in Alzheimer’s Disease." Journal of Proteome Research, vol. 19, no. 3, 2020, https://doi.org/10.1021/acs.jproteome.9b00824.